{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:00:35Z","timestamp":1793037635664,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Program of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173604"],"award-info":[{"award-number":["82173604"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10067-023-06840-0","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T18:02:02Z","timestamp":1702576922000},"page":"645-655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sema4D as a biomarker for Predicting rheumatoid arthritis disease activity"],"prefix":"10.1007","volume":"43","author":[{"given":"Huiyuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruobing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3400-2509","authenticated-orcid":false,"given":"Lingyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"issue":"Suppl 10","key":"6840_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.40321","volume":"69","author":"ACR\/ARHP Annual Meeting Abstract Supplement","year":"2017","unstructured":"ACR\/ARHP Annual Meeting Abstract Supplement (2017) Arthritis Rheumatol 69(Suppl 10):1\u20134426. https:\/\/doi.org\/10.1002\/art.40321","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"6840_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","volume":"4","author":"Y Alamanos","year":"2005","unstructured":"Alamanos Y, Drosos AA (2005) Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 4(3):130\u20136","journal-title":"Autoimmun Rev"},{"key":"6840_CR3","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1186\/ar3374","volume":"13","author":"A Sandoo","year":"2011","unstructured":"Sandoo A, Carroll D, Metsios GS et al (2011) The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 13:R99","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"6840_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13075-017-1449-z","volume":"19","author":"L Zhou","year":"2017","unstructured":"Zhou L, Wang G, Liu X, Song J, Chen L, Xu H (2017) Matrix metalloproteinase-3 and the 7-joint ultrasound score in the assessment of disease activity and therapeutic efficacy in patients with moderate to severe rheumatoid arthritis. Arthritis Res Ther 19(1):250","journal-title":"Arthritis Res Ther"},{"key":"6840_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2019t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u201348","journal-title":"Arthritis Rheum"},{"issue":"11","key":"6840_CR6","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1111\/1756-185X.13110","volume":"21","author":"P Dhaon","year":"2018","unstructured":"Dhaon P, Das SK, Srivastava R, Dhakad U (2018) Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients. Int J Rheum Dis 21(11):1933\u20131939","journal-title":"Int J Rheum Dis"},{"key":"6840_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4049\/jimmunol.148.2.318","volume":"148","author":"C Bougeret","year":"1992","unstructured":"Bougeret C, Mansur IG, Dastot H, Schmid M, Mahouy G, Bensussan A et al (1992) Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol 148:318\u2013323","journal-title":"J Immunol"},{"key":"6840_CR8","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.4049\/jimmunol.166.7.4341","volume":"166","author":"A Elhabazi","year":"2001","unstructured":"Elhabazi A, Delaire S, Bensussan A, Boumsell L, Bismuth G (2001) Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J Immunol 166:4341\u20137","journal-title":"J Immunol"},{"key":"6840_CR9","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1182\/blood.V97.11.3498","volume":"97","author":"X Wang","year":"2001","unstructured":"Wang X, Kumanogoh A, Watanabe C, Shi W, Yoshida K, Kikutani H (2001) Functional soluble CD100\/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood 97:3498\u20133504","journal-title":"Blood"},{"key":"6840_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nature11000","volume":"485","author":"M Hayashi","year":"2012","unstructured":"Hayashi M, Nakashima T, Taniguchi M, Kodama T, Kumanogoh A, Takayanagi H (2012) Osteoprotection by semaphorin 3A. Nature 485:69\u201374","journal-title":"Nature"},{"key":"6840_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature12115","volume":"497","author":"T Fukuda","year":"2013","unstructured":"Fukuda T, Takeda S, Xu R, Ochi H, Sunamura S, Sato T et al (2013) Sema3A regulates bone-mass accrual through sensory innervations. Nature 497:490\u2013493","journal-title":"Nature"},{"issue":"10","key":"6840_CR12","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/intimm\/dxh307","volume":"17","author":"A Kumanogoh","year":"2005","unstructured":"Kumanogoh A, Shikina T, Watanabe C et al (2005) Requirement for CD100- CD72 interactions in fine- tuning of B- cell antigen receptor signaling and homeostatic maintenance of the B- cell compartment. Int Immu Nol 17(10):1277\u20131282","journal-title":"Int Immu Nol"},{"issue":"8","key":"6840_CR13","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1182\/blood-2004-10-3873","volume":"105","author":"S Deaglio","year":"2005","unstructured":"Deaglio S, Vaisitti T, Bergui L et al (2005) CD38 and CD100 lead a network of surface receptors relaying positive signals for B- CLL growth and survival. Blood 105(8):3042\u20133050","journal-title":"Blood"},{"issue":"5","key":"6840_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1074-7613(00)00062-5","volume":"13","author":"A Kumanogoh","year":"2000","unstructured":"Kumanogoh A, Watanabe C, Lee I et al (2000) Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 13(5):621\u2013631","journal-title":"Immunity"},{"key":"6840_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1155\/2018\/2318386","volume":"2018","author":"Y-J Ha","year":"2018","unstructured":"Ha Y-J, Han DW, Kim JH, Chung SW, Kang EH, Song YW, Lee YJ, Rizzo R (2018) Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis. Disease Markers 2018:10","journal-title":"Disease Markers"},{"key":"6840_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jbi.2014.02.013","volume":"48","author":"K Hajian-Tilaki","year":"2014","unstructured":"Hajian-Tilaki K (2014) Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform 48:193\u2013204","journal-title":"J Biomed Inform"},{"issue":"4","key":"6840_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3349\/ymj.2005.46.4.464","volume":"46","author":"YS Shin","year":"2005","unstructured":"Shin YS, Choi JH, Nahm DH et al (2005) Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis. Yonsei Med J 46(4):464\u2013470","journal-title":"Yonsei Med J"},{"issue":"8","key":"6840_CR18","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1136\/annrheumdis-2012-201960","volume":"72","author":"JH Humphreys","year":"2013","unstructured":"Humphreys JH, Verstappen SM, Hyrich KL, Chipping JR, Marshall T, Symmons DP (2013) The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR\/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register. Ann Rheum Dis 72(8):1315\u201320","journal-title":"Ann Rheum Dis"},{"key":"6840_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/117727190700200007","volume":"2","author":"C Chou","year":"2007","unstructured":"Chou C, Liao H, Chen C et al (2007) The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases. Biomark Insights 2:165\u2013171","journal-title":"Biomark Insights"},{"issue":"9","key":"6840_CR20","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/art.41701","volume":"73","author":"J Avouac","year":"2021","unstructured":"Avouac J, Pezet S, Vandebeuque E, Orvain C, Gonzalez V, Marin G, Mouterde G, Da\u00efen C, Allanore Y (2021) Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis. Arthritis Rheumatol 73(9):1579\u20131588. https:\/\/doi.org\/10.1002\/art.41701","journal-title":"Arthritis Rheumatol"},{"key":"6840_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13238-010-0002-5","volume":"1","author":"EA Lin","year":"2010","unstructured":"Lin EA, Liu CJ (2010) The role of ADAMTSs in arthritis. Protein Cell 1:33\u201347","journal-title":"Protein Cell"},{"key":"6840_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.mam.2008.08.001","volume":"29","author":"DR Edwards","year":"2008","unstructured":"Edwards DR, Handsley MM, Pennington CJ (2008) The ADAM metalloproteinases. Mol Aspects Med 29:258\u2013289","journal-title":"Mol Aspects Med"},{"key":"6840_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2741\/1817","volume":"11","author":"PS Burrage","year":"2006","unstructured":"Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. Front Biosci 11:529\u2013543","journal-title":"Front Biosci"},{"issue":"670\u20136","key":"6840_CR24","first-page":"22","volume":"22","author":"A Kumanogh","year":"2001","unstructured":"Kumanogh A, Kikutani H (2001) The CD100-CD72 interaction: a novel mechanism of immune regulation. Trends Immunol 22(670\u20136):22","journal-title":"Trends Immunol"},{"issue":"20","key":"6840_CR25","first-page":"1567","volume":"100","author":"QZ Yang","year":"2020","unstructured":"Yang QZ, Ma XB, Li YH, Li YN, Zhong YC, Zhang XW (2020) Correlation analysis of Sema4D with rheumatoid arthritis disease activity, bone destruction and rheumatoid arthritis-related interstitial lung disease. Zhonghua Yi Xue Za Zhi 100(20):1567\u20131572","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2018","key":"6840_CR26","first-page":"2318386","volume":"14","author":"YJ Ha","year":"2018","unstructured":"Ha YJ, Han DW, Kim JH, Chung SW, Kang EH, Song YW, Lee YJ (2018) Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis. Dis Markers 14(2018):2318386","journal-title":"Dis Markers"},{"issue":"6","key":"6840_CR27","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/art.39086","volume":"67","author":"Y Yoshida","year":"2015","unstructured":"Yoshida Y, Ogata A, Kang S et al (2015) Semaphorin 4D contrib-utes to rheumatoid arthritis by inducing inflammatory cyto-kine production: pathogenic and therapeutic implications. Arthritis Rheumatol 67(6):1481\u20131490","journal-title":"Arthritis Rheumatol"},{"key":"6840_CR28","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.pharep.2014.05.004","volume":"66","author":"G Cessak","year":"2014","unstructured":"Cessak G, Kuzawinska O, Burda A, Lis K, Wojnar M, Mirowska-Guzel D et al (2014) TNF inhibitors: mechanisms of action, approved and off-label indications. Pharmacol Rep 66:836\u2013844","journal-title":"Pharmacol Rep"},{"issue":"Suppl","key":"6840_CR29","first-page":"5s","volume":"32","author":"A Patnaik","year":"2014","unstructured":"Patnaik A, Ramanathan RK, Rasco DW, Weiss GJ, Campello-Iddison V, Eddington C et al (2014) Phase 1 study of VX15\/2503, a humanized IgG4 anti-Sema4D antibody, in advanced cancer patients [abstract]. J Clin Oncol 32(Suppl):5s","journal-title":"J Clin Oncol"},{"issue":"4","key":"6840_CR30","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1136\/annrheumdis-2013-204154","volume":"73","author":"J Shi","year":"2014","unstructured":"Shi J, van de Stadt LA, Levarht EW et al (2014) Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis 73(4):780\u2013783","journal-title":"Ann Rheum Dis"},{"issue":"42","key":"6840_CR31","doi-asserted-by":"publisher","first-page":"17372","DOI":"10.1073\/pnas.1114465108","volume":"108","author":"J Shi","year":"2011","unstructured":"Shi J, Knevel R, Suwannalai P et al (2011) Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci USA 108(42):17372\u201317377","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06840-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06840-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06840-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T11:12:58Z","timestamp":1706785978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06840-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["6840"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06840-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"10 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by Institutional Medical Ethics Review Board of the First Affiliated Hospital of China Medical University (AF-SOP-07\u20131.0\u201301). Informed written consent was obtained from all study participants according to the principlesof the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of the subjects provided written informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}